Zika virus: what do we know?

Clinical Microbiology and Infection

Volumn 22, Issue 6, 2016, Pages 494-496

  Musso, D ^a   Baud, D ^b   Gubler, D J ^c  

^a INSTITUT LOUIS MALARDÉ   (French Polynesia)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M;

AMNIOCENTESIS; CHIKUNGUNYA; CROSS REACTION; DENGUE; EDITORIAL; EPIDEMIC; GUILLAIN BARRE SYNDROME; HUMAN; MICROCEPHALY; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEROLOGY; VIRUS DETECTION; VIRUS VIRULENCE; WORLD HEALTH ORGANIZATION; ZIKA FEVER; ZIKA VIRUS; COMPLICATION; DISEASE TRANSMISSION; GUILLAIN-BARRE SYNDROME; ISOLATION AND PURIFICATION; TRANSMISSION; ZIKA VIRUS INFECTION;

DISEASE TRANSMISSION, INFECTIOUS; GUILLAIN-BARRE SYNDROME; HUMANS; MICROCEPHALY; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 84969677844     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2016.03.032     Document Type: Editorial

References (23)

1. [1] Musso, D., Gubler, D.J., Zika virus. Clin Microbiol Rev, 29, 2016 (Epub ahead of print).
2. [2] World Health Organization, Zika situation report. 10 March 2016 Available at: http://www.who.int/emergencies/zika-virus/situation-report/10-march-2016/en/.
3. [3] Oehler, E., Watrin, L., Larre, P., Leparc-Goffart, I., Lastere, S., Valour, F., et al. Zika virus infection complicated by Guillain–Barré syndrome—case report, French Polynesia, December 2013. Euro Surveill, 19, 2014 pii: 20720.
4. [4] Besnard, M., Lastère, S., Teissier, A., Cao-Lormeau, V., Musso, D., Evidence of perinatal transmission of Zika virus, French Polynesia, December 2013 and February 2014. Euro Surveill, 19, 2014 pii: 20751.
5. [5] Musso, D., Roche, C., Robin, E., Nhan, T., Teissier, A., Cao-Lormeau, V.M., Potenial sexual transmission of Zika virus. Emerg Infect Dis 21 (2015), 359–361.
6. [6] Musso, D., Nhan, T., Robin, E., Roche, C., Bierlaire, D., Zisou, K., et al. Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014. Euro Surveill, 19, 2014 pii: 20771.
7. [7] Korhonen, E.M., Huhtamo, E., Smura, T., Kallio-Kokko, H., Raassina, M., Vapalahti, O., Zika virus infection in a traveller returning from the Maldives, June 2015. Euro Surveill, 21, 2016.
8. [8] Samarasekera, U., Triunfol, M., Concern over Zika virus grips the world. Lancet 387 (2016), 521–524.
9. [9] Gourinat, A.C., O'Connor, O., Calvez, E., Goarant, C., Dupont-Rouzeyrol, M., Detection of Zika virus in urine. Emerg Infect Dis 21 (2015), 84–86.
10. [10] Lanciotti, R.S., Kosoy, O.L., Laven, J.J., Velez, J.O., Lambert, A.J., Johnson, A.J., et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis 14 (2008), 1232–1239.
11. [11] Hills, S.L., Russell, K., Hennessey, M., Williams, C., Oster, A.M., Fischer, M., et al. Transmission of Zika virus through sexual contact with travelers to areas of ongoing transmission—continental United States, 2016. MMWR Morb Mortal Wkly Rep 65 (2016), 215–216.
12. [12] Chouin-Carneiro, T., Vega-Rua, A., Vazeille, M., Yebakima, A., Girod, R., Goindin, D., et al. Differential susceptibilities of Aedes aegypti and Aedes albopictus from the Americas to Zika Virus. PLoS Negl Trop Dis, 10, 2016, e0004543.
13. [13] Cao-Lormeau, V., Blake, A., Mons, S., Lastere, S., Roche, C., Vanhomwegen, J., et al. Guillain–Barré Syndrome outbreak caused by ZIKA virus infection in French Polynesia: a case control study. Lancet, 2016 pii: S0140-6736(16) 00562–6.
14. [14] Brasil, P., Pereira, J.P., Raja Gabaglia, C., Damasceno, L., Wakimoto, M., Ribeiro Nogueira, R.M., et al. Zika virus infection in pregnant women in Rio de Janeiro—preliminary report. N Engl J Med, 2016 (Epub ahead of print).
15. [15] Musso, D., Baud, D., Zika virus : time to move from case reports to case control. Lancet Infect Dis, 3099, 2016 pii: S1473-3099(16) 00096–7.
16. [16] Oduyebo, T., Petersen, E.E., Rasmussen, S.A., Mead, P.S., Meaney-Delman, D., Renquist, C.M., et al. Update: interim guidelines for health care providers caring for pregnant women and women of reproductive age with possible Zika virus exposure—United States, 2016. MMWR Morb Mortal Wkly Rep 65 (2016), 122–127.
17. [17] Vouga, M., Musso, D., Van Mieghem, T., Baud, D., CDC guidelines for pregnant women during the Zika outbreak. Lancet 287 (2016), 843–844.
18. [18] Baud, D., Mieghem, T.V., Musso, D., Truttmann, A.C., Manchaud, A., Vouga, M., Materno-fetal specialist's guidelines for clinical management of pregnant women exposed to Zika virus. Lancet Infect Dis, 2016 (Epub ahead of print).
19. [19] Roa, M., Zika virus outbreak: reproductive health and rights in Latin America. Lancet, 387, 2016, 843.
20. [20] Faria, N.R., Azevedo Rdo, S., Kraemer, M.U., Souza, R., Cunha, M.S., Hill, S.C., et al. Zika virus in the Americas: early epidemiological and genetic findings. Science, 2016 pii: aaf5036. (Epub ahead of print).
21. [21] Shakir, R., Neurological expertise is essential for Zika virus infection. Lancet Neurol 15 (2016), 353–354.
22. [22] Food and Drug Administration, Recommendations for donor screening, deferral, and product management to reduce the risk of transfusion–transmission of Zika virus guidance for industry. 2016 Available at: http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/UCM486360.pdf.
23. [23] International Federation of Red Cross and Red Crescent Societies, World Health Organization, UNICEF, Risk communication and community engagement for Zika virus prevention and control. 2016 Available at: http://www.who.int/csr/resources/publications/zika/community-engagement/en/.